These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15877725)

  • 21. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
    Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
    Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No improvement in renal cell carcinoma survival: a population-based study in the Netherlands.
    Aben KK; Luth TK; Janssen-Heijnen ML; Mulders PF; Kiemeney LA; van Spronsen DJ
    Eur J Cancer; 2008 Aug; 44(12):1701-9. PubMed ID: 18502115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapy options in metastatic renal cell cancer: where we are and where we are going.
    Passalacqua R; Buti S; Tomasello G; Longarini R; Brighenti M; Dalla Chiesa M
    Expert Rev Anticancer Ther; 2006 Oct; 6(10):1459-72. PubMed ID: 17069530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of adrenal involvement and assessing adrenal function in patients with renal cell carcinoma: is ipsilateral adrenalectomy indispensable during radical nephrectomy?
    Kobayashi T; Nakamura E; Ogura K; Ogawa O
    BJU Int; 2005 Oct; 96(6):916. PubMed ID: 16153232
    [No Abstract]   [Full Text] [Related]  

  • 25. Cytoreductive nephrectomy in metastatic renal cell carcinoma.
    Margulis V; Matin SF; Wood CG
    Curr Opin Urol; 2008 Sep; 18(5):474-80. PubMed ID: 18670270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytoreductive nephrectomy for metastatic renal cell carcinoma: is it still imperative in the era of targeted therapy?
    Pantuck AJ; Belldegrun AS; Figlin RA
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):693s-696s. PubMed ID: 17255295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conclusion and future directions.
    Samlowski WE; Vogelzang NJ
    Cancer J; 2008; 14(5):330-2. PubMed ID: 18836339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of metastatic renal cell carcinoma: current trends.
    Mohammed A; Shergill I; Little B
    Expert Rev Mol Diagn; 2009 Jan; 9(1):75-83. PubMed ID: 19099350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapy strategies for advanced renal cell carcinoma].
    Staehler M; Haseke N; Schöppler G; Stadler T; Adam C; Stief CG
    Urologe A; 2006 Jan; 45(1):99-110, quiz 111-2. PubMed ID: 16372186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunotherapy against metastatic renal cell carcinoma with mature dendritic cells.
    Matsumoto A; Haraguchi K; Takahashi T; Azuma T; Kanda Y; Tomita K; Kurokawa M; Ogawa S; Takahashi K; Chiba S; Kitamura T
    Int J Urol; 2007 Apr; 14(4):277-83. PubMed ID: 17470153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytoreductive nephrectomy in metastatic renal cell carcinoma.
    Healy KA; Marshall FF; Ogan K
    Expert Rev Anticancer Ther; 2006 Aug; 6(8):1295-304. PubMed ID: 16925495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The therapeutic value of adrenalectomy in case of solitary metastatic spread originating from primary renal cell cancer.
    Kuczyk M; Wegener G; Jonas U
    Eur Urol; 2005 Aug; 48(2):252-7. PubMed ID: 15936136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re: Capitanio et al.: Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study. (Urology 2008;72:1090-1095).
    Chung SD; Chu SH; Tsai CC
    Urology; 2009 Mar; 73(3):682-3; author reply 683-4. PubMed ID: 19248907
    [No Abstract]   [Full Text] [Related]  

  • 34. Renal cell carcinoma.
    Rini BI; Campbell SC; Rathmell WK
    Curr Opin Oncol; 2006 May; 18(3):289-96. PubMed ID: 16552243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccines in renal cell carcinoma.
    Kübler H; Vieweg J
    Semin Oncol; 2006 Oct; 33(5):614-24. PubMed ID: 17045091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dendritic cells for the treatment of metastatic renal cell carcinoma: at a low ebb?
    Patard JJ
    Eur Urol; 2006 Jul; 50(1):11-3. PubMed ID: 16713068
    [No Abstract]   [Full Text] [Related]  

  • 37. Novel treatments for metastatic renal cell carcinoma.
    van Spronsen DJ; Mulders PF; De Mulder PH
    Crit Rev Oncol Hematol; 2005 Sep; 55(3):177-91. PubMed ID: 15979888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New treatment of metastatic renal cancer. The Danish Society of Clinical Oncology].
    Sengeløv L; Geertsen PF;
    Ugeskr Laeger; 2007 Mar; 169(12):1117. PubMed ID: 17394828
    [No Abstract]   [Full Text] [Related]  

  • 39. For: Radical nephrectomy in the setting of metastatic renal cell cancer: proceed judiciously.
    Aron M; Gill IS
    J Urol; 2009 Sep; 182(3):832-3. PubMed ID: 19643447
    [No Abstract]   [Full Text] [Related]  

  • 40. Prognostic factors of metastatic renal cell carcinoma after failure of immunotherapy: new paradigm from a large phase III trial with shark cartilage extract AE 941.
    Escudier B; Choueiri TK; Oudard S; Szczylik C; Négrier S; Ravaud A; Chevreau C; Venner P; Champagne P; Croteau D; Dupont E; Hariton C; Bukowski RM
    J Urol; 2007 Nov; 178(5):1901-5. PubMed ID: 17868728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.